ABSTRACT
The novel COVID-19 emerged from Wuhan and has spread worldwide. Globally, there are about 16.3 million confirmed cases including 650,805 deaths and still counting, during which the USA, Brazil, India, Russia, and South Africa are the most affected countries as of July 28, 2020. Considering the potential spread of the disease and precipitously increasing the number of cases, the demand for rapid development of therapies and vaccines is increased. Vaccines are amongst the essential tools to manage SARS-CoV-2, several institutions, and firms worldwide running tough for the development of vaccines towards coronavirus. Several vaccine candidates, using different technologies, especially towards spike proteins because of it’s important characteristics in viral infection. Based on the prevailing outbreak right here we focus on modern-day updates on the development of vaccine candidates against SARS-CoV-2.